FIGURE

Fig 1

ID

ZDB-FIG-250522-41

Publication

Cao et al., 2025 - Therapeutic potential of a choline-zinc-vitamin E nutraceutical complex in ameliorating thioacetamide-induced nonalcoholic fatty liver pathology in zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig 1

Intensity of zebrafish liver fat staining after treatment with nutraceutical complex.

(A) Normal control group; (B) Model control group; (C) The positive control group: polyunsaturated phosphatidylcholine 50.0 μg/mL; (D) Low dose of nutraceutical complex: 125 μg/mL; (E) Middle dose of nutraceutical complex: 250 μg/mL; (F) High dose of nutraceutical complex: 500 μg/mL; (G) Low dose of choline bitartrate control group: 81.0 μg/mL; (H) Middle dose of choline bitartrate control group: 162 μg/mL; (I) High dose of choline bitartrate control group: 316 μg/mL. The location of the liver is marked with a yellow dotted line in the example figure.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS One